165 related articles for article (PubMed ID: 27104682)
1. MRI characteristics for the differential diagnosis of benign and malignant small solitary hypovascular hepatic nodules.
Qian H; Li S; Ji M; Lin G
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):749-56. PubMed ID: 27104682
[TBL] [Abstract][Full Text] [Related]
2. [Solitary hypovascular hepatic nodules: MR characterization and differential diagnosis].
Qian H; Lin G; Ji M; Lu C; Li C
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):445-50. PubMed ID: 26463149
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
[TBL] [Abstract][Full Text] [Related]
4. Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI.
Li S; Qian H; Peng Y; Jia H; Lin G
Sci Rep; 2017 Aug; 7(1):8084. PubMed ID: 28808285
[TBL] [Abstract][Full Text] [Related]
5. Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.
Fang J; Ma X; Yu D; Ma X; Xiang Y; Guo L
Eur Radiol; 2017 Sep; 27(9):3563-3573. PubMed ID: 28124105
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.
Chang AI; Kim YK; Min JH; Lee J; Kim H; Lee SJ
Abdom Radiol (NY); 2019 Apr; 44(4):1395-1406. PubMed ID: 30515535
[TBL] [Abstract][Full Text] [Related]
7. Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
Fujita N; Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Moirta K; Shirabe K; Aishima S; Wang H; Oda Y; Honda H
Eur Radiol; 2017 Feb; 27(2):498-506. PubMed ID: 27165138
[TBL] [Abstract][Full Text] [Related]
8. The CT appearances for differentiating of peripheral, mass-forming cholangiocarcinoma and liver meatastases from colorectal adenocarcinoma.
Apisarnthanarak P; Pansri C; Maungsomboon K; Thamtorawat S
J Med Assoc Thai; 2014 Apr; 97(4):415-22. PubMed ID: 24964684
[TBL] [Abstract][Full Text] [Related]
9. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
[TBL] [Abstract][Full Text] [Related]
10. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
[TBL] [Abstract][Full Text] [Related]
11. Uncommon liver tumors: Case report and literature review.
Wu CH; Chiu NC; Yeh YC; Kuo Y; Yu SS; Weng CY; Liu CA; Chou YH; Chiou YY
Medicine (Baltimore); 2016 Sep; 95(39):e4952. PubMed ID: 27684838
[TBL] [Abstract][Full Text] [Related]
12. Benign focal liver lesions masquerading as primary liver cancers on MRI.
Subramanian M; Low HM; Kim MJ; Tan CH
Diagn Interv Radiol; 2020 May; 26(3):168-175. PubMed ID: 32229432
[TBL] [Abstract][Full Text] [Related]
13. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
[TBL] [Abstract][Full Text] [Related]
14. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F
J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
[TBL] [Abstract][Full Text] [Related]
15. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
[TBL] [Abstract][Full Text] [Related]
17. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
18. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
[TBL] [Abstract][Full Text] [Related]
19. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
20. Solitary hypovascular hepatic nodules: comparison and differentiation between peripheral nodular cholangiocarcinoma and atypical liver hemangioma with MRI.
Wang H; Guo S
Transl Cancer Res; 2023 Sep; 12(9):2308-2318. PubMed ID: 37859741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
